Machine Learning

14 October 2022

Biodata and AI in Drug Discovery – October 2022

Cancer driving mutations identified using machine learning

Predicting the success of COVID-19 clinical trials

Predicting FDA approval using artificial intelligence

Neural networks for predicting bioactivity descriptors

Predicting biomarkers for immunotherapy response using machine learning

The role of artificial intelligence (AI) and big data in drug discovery

Using machine learning to model the fitness of cancer cells and predict drug resistance

Machine learning used to study the progression of metastatic prostate cancer (mCRPC)

NRPminer: A machine learning algorithm that explores nature to discover new drugs